Articles tagged with Inflammation
A Canadian researcher has identified a small peptide, 15-1, which blocks fragments of the ubiquitous sugar molecule hyaluronan and promotes robust healing and less scarring in deep wounds. The study found that this peptide effectively reduced wound contraction, collagen deposits, inflammation, and growth of unwanted new blood vessels.
A team of scientists from Kiel University, along with international colleagues, has identified interleukin-27 as a key player in counteracting inflammation. This discovery could lead to new treatments for chronic inflammatory diseases.
Researchers found that bacteria from the mouth and gut can enter the body and contribute to inflammation and plaque rupture in atherosclerosis. The study identified specific bacteria, such as Pseudomonas luteola and Chlamydia pneumoniae, which were present in both atherosclerotic plaques and the mouths and guts of patients.
A diet study led by Lund University found that a specific diet high in antioxidants, omega fatty acids, and wholegrain products can improve memory and cognitive function. The diet also significantly reduced blood lipids, blood pressure, and inflammation markers.
Research found no evidence that doubling inhaled corticosteroids reduces need for rescue oral steroids, contradicting common practice. Increasing doses may provide false reassurance and undermine effectiveness of daily inhaled steroids.
A study found that malnutrition and inflammation status are key to understanding the effects of high cholesterol on kidney disease patients. Patients with malnutrition and/or inflammation had an inverse relationship between cholesterol levels and cardiovascular events, unlike those without these conditions.
Researchers found that mice treated with chromium picolinate had lower levels of albuminuria compared to untreated diabetic mice. The supplement reduced inflammation by affecting IDO, IL-6, and IL-7, suggesting a potential therapeutic effect.
A Mayo Clinic study found that nerve inflammation may cause postsurgical neuropathy in some patients, leading to pain, numbness, and weakness. Immunotherapy can quickly improve symptoms in these cases.
Researchers have discovered a new function of interferons, which inhibit the production of IL-1beta protein and suppress inflammation. This finding has significant implications for treating autoimmune and inflammatory diseases.
A study found that kidney transplants showing fibrosis and inflammation after one year are at increased risk of long-term transplant failure. Routine biopsies can help identify these abnormal signs and predict potential targets for early preventative treatment.
A new study found that prenatal exposure to low doses of atrazine causes prostate inflammation and delays puberty in male rats. The incidence of prostate inflammation increased significantly with the strength of the doses, while puberty was also delayed in animals exposed to atrazine.
Hydrogen sulfide has been found to be present in the fluid inside human knee joint synovial fluid and may play a role in reducing inflammation. The study found higher levels of hydrogen sulfide in patients with rheumatoid arthritis, associated with lower inflammation and disease activity.
Researchers found that sulfasalazine enhances the body's ability to clear fungal debris from the lungs, reducing inflammation and promoting better lung function. The study offers a new avenue for research on Pneumocystis pneumonia and may lead to improved treatment options for patients with weakened immune systems.
NYU researchers found that periodontal inflammation increases cognitive dysfunction risk in healthy individuals and those with Alzheimer's. The study linked gum inflammation to brain inflammation, neurodegeneration, and Alzheimer's disease.
Researchers found that angiotensin II promotes brain inflammation in multiple sclerosis, but blocking its receptors with Candesartan decreases inflammation and resolves paralysis. The protective mechanism works only in the central nervous system, and the study suggests a new potential treatment for MS.
Researchers are testing Lexiscan, a pharmacologic stress agent, in a multicenter clinical trial to reduce inflammation in sickle cell disease. The trial aims to improve symptoms such as pain and breathing problems, which can be fatal.
A double-blind, randomized placebo-controlled trial found that high doses of ursodeoxycholic acid failed to improve overall liver histology in patients with nonalcoholic steatohepatitis. Only lobular inflammation showed significant improvement in certain subgroups.
A high-fat diet is found to activate nuclear factor kappa B (NF-κB) in the prostate, leading to inflammation, oxidative stress, and proliferation. The study provides direct evidence of a link between a high-fat diet and an increased risk of benign prostatic hyperplasia, prostatitis, and prostate cancer.
A recent study has identified luteolin as the most effective inhibitor of TBK1, an enzyme that activates biochemical signals leading to inflammation. Luteolin is found in various plant-based foods and has already been recognized for its anti-inflammatory properties.
Researchers investigated the potential therapeutic effects of local anesthetics on experimental inflammatory bowel disease in rats. They found some improvement in macroscopic inflammation at the application site, but not supported by microscopic findings.
A new nonsteroidal therapy, IGFBP-3, has significantly decreased disease signs of asthma in mice by inhibiting the NF-kB inflammatory pathway. This could lead to a new alternative therapy for patients resistant to current steroid treatments.
A recent study found that patients taking celecoxib (a COX-2 selective NSAID) had lower rates of gastrointestinal adverse events compared to those taking diclofenac slow release plus omeprazole. The CONDOR study suggests that celecoxib may be a safer option for arthritis patients at increased gastrointestinal risk.
Scientists have discovered that platelets play a crucial role in cerebral malaria, a fatal form of the disease that ravages the brain. By targeting platelets, researchers hope to develop new treatment options for this devastating condition.
Researchers found some improvement in macroscopic inflammation with local anesthetics, but microscopic findings did not support these results. Local anesthetics may have potential therapeutic effects on inflammatory bowel disease based on their ability to reduce neuronal activity and subsequent inflammation.
Researchers found that eating pistachios increases blood serum levels of lutein, beta-carotene, and gamma-tocopherol. These antioxidants may help lower oxidized LDL concentrations, which can contribute to inflammation and plaque buildup inside blood vessels.
A study by UC Davis researchers has identified a blood component, lipoprotein-associated phospholipase A2 (Lp-PLA2), as a predictor of coronary artery disease in African-Americans. The finding highlights the role of inflammation in vascular disease among this ethnic group and may lead to more targeted treatment approaches.
Researchers at Michigan State University discovered that cholesterol crystals form in the arterial wall and activate a biomarker called NLRP3, inducing inflammation. This early cause of inflammation could lead to new treatments targeting cholesterol crystal deposits and inflammatory biomarkers.
Researchers at Karolinska Institutet have developed a vaccine that can block the immune reaction causing atherosclerosis, reducing disease by 60-70%. The vaccine targets T cells reacting to native LDL particles, reversing previous findings on antioxidants' ineffectiveness against cardiovascular disease.
Researchers found biochemical mediators of inflammation produced by activated macrophages, which stimulate antioxidant and anti-inflammatory responses. These findings could lead to the development of new treatments for inflammatory diseases linked to omega-3 fatty acids and aspirin.
A study by Case Western Reserve University found that subjects with both high gum inflammation levels and moderate to severe prostatitis had higher PSA or inflammation levels. This suggests that inflammation outside the prostate gland may be causing an inflammatory reaction, which could explain why PSA levels can be high in prostatitis.
A dual FXR and TGR5 agonist decreases liver damage and modulates hepatic inflammation and fibrosis in a mouse model of PSC. FXR and TGR5 agonists regulate bile acids, glucose, lipids and inflammation.
Researchers have isolated a portion of the adenovirus responsible for causing pink eye, finding that its protein coating is the key to inflammation in the eyes. This discovery offers new hope for developing a treatment for this highly contagious and common condition.
Researchers have discovered that an enzyme found in white blood cells can break down carbon nanotubes into harmless components. This breakthrough finding has significant implications for the future use of carbon nanotubes in medicine, potentially rendering them harmless and reducing toxicity.
A unique St. John's wort collection curated by ARS scientists provides university collaborators with genetically diverse sources of the herb to study its medicinal potential. Researchers are screening the collection for biologically active compounds that may combat viral infections, reduce inflammation, or improve digestive health.
A novel anti-inflammatory drug, ATB-346, has shown promise in relieving inflammation symptoms while reducing bleeding and intestinal damage caused by commonly used NSAIDs. The researchers found that ATB-346 is at least as effective as naproxen in animal models and is significantly safer.
A new study found that consuming orange juice with a high-fat meal reduces oxidative stress and inflammation in blood vessels, which can contribute to heart attacks and strokes. The flavonoids naringenin and hesperidin in orange juice are believed to be the key players in this process.
Researchers found that a certain form of body fat inflammation is necessary for fat cell turnover in lean, healthy individuals. This challenges the theory that inflammation in adipose tissue only causes insulin resistance and type 2 diabetes.
Researchers found that an experimental oral drug lowered blood sugar levels and reduced inflammatory proteins in diabetic mice. The study suggests that targeting the MIF protein could be a viable therapeutic approach to treating Type 2 diabetes.
Researchers analyzed DNA from 40 diverse Echinacea populations to understand the plant's genetic diversity. The study found that the species likely originated in southern refuges on both sides of the Mississippi River and hybridized as they moved northward, leading to blurred genetic distinctions.
Researchers found that an enzyme suspected of causing inflammation has only limited role in spurring edema. A two-hit model is proposed to explain vascular permeability regulation, suggesting other drug targets for preventing or reversing inflammation and edema.
A recent UNC study found that obese children as young as 3 years old have elevated levels of C-reactive protein and other inflammatory markers, indicating a strong relationship between weight status and inflammation. The study suggests that obesity may be unhealthy for young children, even at a young age.
Researchers found that CRP concentration is associated with future risk of a wide range of common diseases, including heart attack, stroke, and various cancers. Most of these associations were explained by known risk factors such as smoking, blood pressure, and obesity.
A newly discovered gene called Brd2 has been found to play a crucial role in regulating body energy balance and protecting against Type 2 diabetes. In mice with a reduced expression of the Brd2 gene, obesity did not lead to diabetes, highlighting the importance of inflammation in this process.
A study by Texas AgriLife Research has linked gene PFKFB3 to metabolic inflammation that leads to diabetes. The researchers believe that a focus on nutrition can prevent or reverse the disease by activating the gene.
Researchers at Karolinska Institutet identify polyphosphate as a key player in the formation of blood clots and inflammation. The study suggests that phosphatases can break down polyphosphate, preventing both conditions.
Researchers at Imperial College London have identified TLR-2 as the trigger that leads to inflammation and damage in atherosclerosis, a condition causing heart attacks and strokes. Blocking this molecule could potentially treat atherosclerosis and reduce the risk of these diseases.
Researchers at UCI discovered a way to boost palmitoylethanolamide (PEA) levels, a potent anti-inflammatory substance. The PEA-boosting compound shows wide-scale promise as an immune-response drug treatment for allergies, illnesses and injuries.
A new study published in Nutrition Journal indicates that XanGo Juice has lowered levels of C-reactive protein (CRP) in overweight and obese people, suggesting potential benefits for heart health and diabetes. The juice also showed significant reductions in body fat percentage and BMI scores.
A recent study found that patients treated with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate. The study also observed higher levels of calcium concentrations in the teriparatide group.
Researchers discovered that dendritic cells in the lung provoke destructive T-cells that attack elastin, causing lung tissue death and emphysema. The study found a link between systemic inflammation and cardiovascular diseases associated with smoking.
Researchers discovered how fish oils convert to Resolvin D2, a chemical that reduces inflammation and may treat conditions like arthritis, sepsis, and stroke. This breakthrough could lead to new treatments for diseases associated with inflammation.
LX211 controls inflammation in non-infectious uveitis, significantly reducing its recurrence rate by 50% at a dose of 0.4 mg/kg twice daily. The treatment also preserves visual acuity and reduces corticosteroid use to minimize vision loss risk.
Researchers found that aspirin and folic acid do not affect inflammation markers in patients with colorectal adenomas. However, low-dose aspirin was found to stabilize C-reactive protein levels, which may be affected by high folate intake.
A new study suggests that platelet-rich plasma (PRP) may catalyze the body's repair mechanisms at areas of injury, improving healing and shortening recovery time. However, more research is needed to determine its clinical effectiveness for chronic tendon conditions, such as tennis elbow and Achilles tendonitis.
Researchers at Medical College of Georgia say blocking a protein that battles infection may help prevent a common cause of vision loss in chronic diseases like diabetes. The protein interleukin-6 prompts inflammation, which can lead to complications such as diabetic retinopathy.
Research found a modestly increased risk of death in patients with lesser degrees of celiac disease-related symptoms. The risk was highest in the first year of follow-up, with cardiovascular disease and malignancy being the main causes of death in celiac disease.
Researchers at University of Michigan have developed a nanoemulsion lotion that sharples curbs bacterial growth and reduces inflammation in second-degree burns. The treatment shows promise in overcoming current creams' limitations, reducing bacterial growth one-thousand-fold compared to control animals.
Patients with polymyositis and dermatomyositis, autoimmune disorders causing muscle inflammation, are at higher risk of developing cardiovascular disease. The study found that immunosuppressive therapies may have a preventive effect against heart attacks, providing hope for patients hesitant to undergo treatment.
Researchers have identified a contaminant in common intravenous treatments that can trigger life-threatening inflammation in critically ill patients. Advanced glycation end products, found in albumin infusion solutions, can cause significant inflammation and death rates in mice, suggesting the need for improved patient outcomes.
Progesterone exposure may increase breast cancer risk by activating genes involved in cell adhesion, survival, and inflammation. The study reveals targets for future work in reducing progesterone's influence on breast cancer development.